Non-ambient conditions in the investigation and manufacturing of drug forms. / Boldyreva, Elena.
In: Current Pharmaceutical Design, Vol. 22, No. 32, 01.09.2016, p. 4981-5000.Research output: Contribution to journal › Review article › peer-review
}
TY - JOUR
T1 - Non-ambient conditions in the investigation and manufacturing of drug forms
AU - Boldyreva, Elena
PY - 2016/9/1
Y1 - 2016/9/1
N2 - For the formation of a drug, a pharmacologically active compound must be prepared in a specific form. The drug must be manufactured, packaged, stored, transported, administred and delivered to a target in the body. To successfully prepare a drug form that will be robust through manufacturing, stable before administration and active with high bioavailability after administration, one needs to produce solid forms with controlled crystal structure and particle size and shape-often as multi-component composites. Considering drugs as materials, one can apply the knowledge of solid-state chemistry and materials science and non-ambient conditions to obtain solid forms with optimized properties. These conditions include, among others, different types of mechanical and ultrasonic treatment, hydrostatic compression, high-temperature or cryogenic spray-drying and crystallization from supercritical solvents. Solid-state reactions (e.g. dehydration or clathrate decomposition) can be effective in accessing metastable polymorphs or in micronizing a sample uniformly. To achieve control over the drug forms and the processes used for their robust manufacturing, one needs to take into account both the thermodynamic and kinetic aspects of their transformations.
AB - For the formation of a drug, a pharmacologically active compound must be prepared in a specific form. The drug must be manufactured, packaged, stored, transported, administred and delivered to a target in the body. To successfully prepare a drug form that will be robust through manufacturing, stable before administration and active with high bioavailability after administration, one needs to produce solid forms with controlled crystal structure and particle size and shape-often as multi-component composites. Considering drugs as materials, one can apply the knowledge of solid-state chemistry and materials science and non-ambient conditions to obtain solid forms with optimized properties. These conditions include, among others, different types of mechanical and ultrasonic treatment, hydrostatic compression, high-temperature or cryogenic spray-drying and crystallization from supercritical solvents. Solid-state reactions (e.g. dehydration or clathrate decomposition) can be effective in accessing metastable polymorphs or in micronizing a sample uniformly. To achieve control over the drug forms and the processes used for their robust manufacturing, one needs to take into account both the thermodynamic and kinetic aspects of their transformations.
KW - Cocrystals
KW - Composites
KW - Cryotechnologies
KW - Drug delivery
KW - Mechanochemistry
KW - Micronization
KW - Polymorphism
KW - Solubilization
UR - http://www.scopus.com/inward/record.url?scp=84995598425&partnerID=8YFLogxK
U2 - 10.2174/1381612822666160804093120
DO - 10.2174/1381612822666160804093120
M3 - Review article
C2 - 27494064
AN - SCOPUS:84995598425
VL - 22
SP - 4981
EP - 5000
JO - Current Pharmaceutical Design
JF - Current Pharmaceutical Design
SN - 1381-6128
IS - 32
ER -
ID: 25461442